TIS 0.00% 0.0¢ tissue therapies limited

Dr Steven Mercer, the CEO said, “The decision to withdraw the...

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 487 Posts.
    Dr Steven Mercer, the CEO said, “The decision to withdraw the request for Scientific Opinion
    does not impact Tissue Therapies’ ongoing plans to obtain approval for VitroGro® ECM in the
    USA. The procedure for US FDA approval for the use of VitroGro® ECM is different from that​
    for CE Mark.

    Interesting that this is the comment he makes.....perhaps we may get approval in the US in the not so distant future.
 
watchlist Created with Sketch. Add TIS (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.